Chengdu-based Biotech Company Developed Reagent Test Kit for New Coronavirus in a week

Authors: Go Chengdu


The Sichuan Maccura Biotechnology Co., Ltd. based in Chengdu developed a reagent test kit for the novel coronavirus (2019-nCoV) within a week.
The Sichuan Maccura Biotechnology Co., Ltd., based in the Chengdu High-tech Industrial Development Zone, recently developed a reagent test kit for the novel coronavirus (2019-nCoV), which will effectively help to speed up the diagnosis process and control the spread of the epidemic.
 reagent test kit for the novel coronavirus
Long Tengxiang, biological reagent R & D director at Maccura said in a media interview that with great efforts, a R & D team of the company developed the test kit within a week. Just after the outbreak of the pneumonia caused by the novel coronavirus, the company was immediately aware of the urgency of developing the diagnosis reagent test kit. Before the full genome sequence was announced, it decided to start the R&D program on January 8. After the release of the whole genome sequence of the virus, the team members sacrificed their Chinese New Year holiday to the hard work, and finally, they successfully developed the first reagent test kit for the new coronavirus in southwest China on January 27.
 reagent test kit for the novel coronavirus
According to Mr. Long, compared with other similar products on the market, the reagent test kit developed by Maccura have four advantages: high accuracy, strong security, short detection time, as well as wide range of application.
Now, the company is stepping up its clinical trials and is making active preparations for the registration with the China National Medical Products Administration. Once approved, it can generate a production capacity for 20,000 people per day.
 reagent test kit for the novel coronavirus  reagent test kit for the novel coronavirus
"Founded in 1994, Maccura has been focusing on the research and manufacture of clinical IVD products, and has developed more than 400 diagnostic products so far, " said Mr. Long, who leads the R & D team with a total of 278 members. Thirty of them, at an average age of less than 30, are the core members for the research and development of the reagent test kit for the new coronavirus. And over 80% of them hold a master's degree or above and are overseas returnees.
(photo by Liu Haiyun)

CDHT Attracts 6 Nobel Laureate-led Start-up Teams

The Kornberg Innovative Bio-macromolecular Drug Research Institute was launched May 10 at the Chengdu Tianfu International Bio-town, Chengdu Hi-tech Zone (CDHT).

May 11, 2018

Nobel Laureate Joins Chengdu TINBRI as Honorary Director

Following the launch of a project led and invested by Nobel laureate Dr. Roger David Kornberg at the Chengdu Tianfu International Bio-Town last week, the Town introduced another Nobel winner on May 15.

May 18, 2018

WuXi AppTec to build biotech industrial park in Chengdu

The launching ceremony of Chengdu WuXi AppTec Life Health Industrial Park was held in Wenjiang District, Chengdu on May 29.

Jun 11, 2018

Nobel Laureate to Work together with Chengdu in Biomedical, Healthcare Industry

A research workstation led by Nobel laureate Dr. Robert Huber was unveiled in Chengdu.

May 29, 2019

Chengdu Tianfu Int’l Biotown Brings in One More Project

By far, the Chengdu Tianfu International Bio-City has attracted a total of 121 projects with a gross investment of more than RMB100 billion.

Sep 29, 2019

Share to WeChat Close
Scan via WeChat!

About Us | Privacy Policy | Terms of Use | Link to Us | Contact Us

蜀ICP备14024942号-1 Go成都